Our study revealed the early alteration in the expression levels of several miRNAs, and particularly the downregulation of miR‐802‐5p and miR‐194‐5p in plasma, and that their common target, MEF2C, is increasingly expressed in the brain along BC metastasis development. The gene discussed is MEF2C; the disease is breast cancer.